These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23143204)

  • 1. Is home monitoring of international normalised ratio safer than clinic-based monitoring?
    Cumberworth A; Mabvuure NT; Hallam MJ; Hindocha S
    Interact Cardiovasc Thorac Surg; 2013 Feb; 16(2):198-201. PubMed ID: 23143204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users.
    Witt DM; Delate T; Clark NP; Martell C; Tran T; Crowther MA; Garcia DA; Ageno W; Hylek EM;
    J Thromb Haemost; 2010 Apr; 8(4):744-9. PubMed ID: 20398186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rivaroxaban vs. warfarin on extended deep venous thromboembolism treatment: A cost analysis.
    Diken AI; Yalçınkaya A; Hanedan MO; Erol ME; Ercen Diken Ö
    Phlebology; 2018 Feb; 33(1):53-59. PubMed ID: 28056701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records.
    Menzin J; Hoesche J; Friedman M; Nichols C; Bergman GE; Crowther M; Garcia D; Jones C
    J Thromb Haemost; 2012 Apr; 10(4):596-605. PubMed ID: 22257107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation early after mechanical valve replacement: improved management with patient self-testing.
    Thompson JL; Burkhart HM; Daly RC; Dearani JA; Joyce LD; Suri RM; Schaff HV
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):599-604. PubMed ID: 22921821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR.
    Sandén P; Renlund H; Svensson PJ; Själander A
    Thromb Haemost; 2017 Jan; 117(1):27-32. PubMed ID: 27652593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-management of oral anticoagulation therapy--methodological and clinical aspects.
    Christensen TD
    Dan Med Bull; 2011 May; 58(5):B4284. PubMed ID: 21535992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of well managed warfarin. A report from the Swedish quality register Auricula.
    Sjögren V; Grzymala-Lubanski B; Renlund H; Friberg L; Lip GY; Svensson PJ; Själander A
    Thromb Haemost; 2015 Jun; 113(6):1370-7. PubMed ID: 25716771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recommended use of INR in the laboratory monitoring of oral anticoagulant treatment].
    Syrjälä M
    Duodecim; 1998; 114(6):573-5. PubMed ID: 11466922
    [No Abstract]   [Full Text] [Related]  

  • 12. Aniticoagulation in patients following prosthetic heart valve replacement.
    Akhtar RP; Abid AR; Zafar H; Khan JS
    Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):10-7. PubMed ID: 19262444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of warfarin in paediatric patients with prosthetic cardiac valves: a retrospective audit.
    Wong CS; Batchelor K; Bua J; Newall F
    Thromb Res; 2011 Oct; 128(4):331-4. PubMed ID: 21620442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial.
    Schulman S; Parpia S; Stewart C; Rudd-Scott L; Julian JA; Levine M
    Ann Intern Med; 2011 Nov; 155(10):653-9, W201-3. PubMed ID: 22084331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warfarin treatment quality and prognosis in patients with mechanical heart valve prosthesis.
    Grzymala-Lubanski B; Svensson PJ; Renlund H; Jeppsson A; Själander A
    Heart; 2017 Feb; 103(3):198-203. PubMed ID: 27590664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation.
    Lind M; Fahlén M; Kosiborod M; Eliasson B; Odén A
    Thromb Res; 2012 Jan; 129(1):32-5. PubMed ID: 21851969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Warfarin Home INR Monitoring vs Office-Based Monitoring: a Retrospective Claims-Based Analysis.
    Van Beek A; Moeyaert M; Ragheb B; Price E; MacEwan JP; Ahmed N; Ansell J
    J Gen Intern Med; 2024 May; 39(7):1127-1134. PubMed ID: 38100006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
    Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of prophylactic oseltamivir on INR in patients on stable warfarin therapy.
    Smith KR; Bryan WE; Townsend ML; Randolph AE; Vanderman AJ; Woodard CL; Brown JN
    J Thromb Thrombolysis; 2020 Aug; 50(2):452-456. PubMed ID: 31898274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial.
    Dignan R; Keech AC; Gebski VJ; Mann KP; Hughes CF;
    Int J Cardiol; 2013 Oct; 168(6):5378-84. PubMed ID: 24083884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.